Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 3/20 | 0.38 |
| ▸ | CNR1 | P21554 | 2/20 | 0.38 |
| ▸ | PDK2 | Q15119 | 6/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.33 |
| ▸ | KMO | O15229 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | TSPO | P30536 | 1/20 | 0.33 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2603611 | 0.98 | CNR2 (0.37) | CNR2CNR1PDK2KDM4EALDH1A1 | |
| SCHEMBL783103 | 0.95 | CNR2 (0.36) | CNR2CNR1PDK2KDM4EALDH1A1 | |
| SCHEMBL782757 | 0.93 | PDK2 (0.35) | CNR2CNR1PDK2KDM4EALDH1A1 | |
| SCHEMBL17245601 | 0.90 | ATM (0.40) | PDK2KDM4EALDH1A1PKMATM | |
| SCHEMBL2603612 | 0.88 | PDK2 (0.36) | CNR2CNR1PDK2ALDH1A1ATM | |
| SCHEMBL17245599 | 0.87 | ATM (0.38) | KDM4EALDH1A1PKMATML3MBTL1 | |
| SCHEMBL782532 | 0.87 | PDK2 (0.37) | CNR2CNR1PDK2KDM4EALDH1A1 | |
| SCHEMBL19653649 | 0.86 | KDM4E (0.37) | PDK2KDM4EATML3MBTL1TSPO | |
| SCHEMBL19195587 | 0.85 | L3MBTL1 (0.39) | PDK2KDM4EALDH1A1ATML3MBTL1 | |
| SCHEMBL19196008 | 0.85 | L3MBTL1 (0.39) | PDK2KDM4EALDH1A1ATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9040172-B2 | Materials for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2015-05-26 | — | — | US | disclosed |
| US-9040172-B2 | Materials for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2015-05-26 | — | — | US | disclosed |
| US-20120097899-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2012-04-26 | — | — | US | disclosed |
| US-20120097899-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2012-04-26 | — | — | US | disclosed |
| WO-2011000455-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENCE DEVICES | MERCK PATENT GMBH (DE) | 2011-01-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120097899-A1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | SLCO4C1, ICMT, NUDC | CNR2 3952/4885CNR1 4446/4885PDK2 1197/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.